Canada willing to discuss COVID-19 vaccine IP waiver -statement

Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in developing the medicines.

"Canada is ready to discuss proposals on a waiver for intellectual property (IP) protection, particular to COVID-19 vaccines, under the WTO Agreement on TRIPS," International Trade Minister Mary Ng said in a statement.

"Our government firmly believes in the importance of protecting IP and recognizes the integral role that industry has played in innovating to develop and deliver life-saving COVID-19 vaccines."

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)